Skip to content

Screening for Obstructive Sleep Apnea in Medical Patients

Screening for Obstructive Sleep Apnea in the General Medical Ward in Tertiary Care Centers in the Middle East

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05980936
Enrollment
0
Registered
2023-08-08
Start date
2023-10-15
Completion date
2025-02-22
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive sleep apnea, Symptomatology, Middle East

Brief summary

Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences. Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.

Detailed description

Obstructive sleep apnea (OSA) is a disease that is highly prevalent in all communities and is associated with adverse cardiovascular events. Screening for OSA is recommended in men and women who have the typical symptoms, including snoring, daytime sleepiness, or abrupt awakenings with choking or gasping. OSA screening is also recommended for those with resistant hypertension, bradyarrhythmias, and atrial fibrillation. Heart failure patients should also be screened for OSA. It is very important to increase the use of OSA screening especially in patients admitted to the medical floor in tertiary care hospitals. No study has evaluated this topic in the Middle East in the past.

Interventions

Patient will be interviewed and asked of there are symptoms of snoring, day somnolence, chocking or gasping during sleep

Sponsors

Jordan Collaborating Cardiology Group
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Willing to sign an informed consent * Patient is admitted to the medical ward in a tertiary hospital

Exclusion criteria

* Patients known to have obstructive sleep apnea. * Patients younger than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants who are found to have obstructive sleep apneaFrom date of study enrollment until the date of first documented diagnosis of obstructive sleep apnea, assessed up to 4 weeks.Those who are found to have symptoms of OSA will be referred for further evaluation to get the final diagnosis of OSA

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026